Three US ETFs with SpaceX exposure, head-to-head: expense ratios, weights, NAV premium traps, IPO event scenarios, $1-of-SpaceX efficiency, plus 3 portfolio templates.
Direct IPO allocation is essentially impossible for retail; ETFs are the practical vehicle. EchoStar (SATS) is a SpaceX-adjacent alternative but a different exposure profile.
21 underwriters (Morgan Stanley, Goldman Sachs, JPMorgan, plus 18 more) all prioritize US/EU/Middle East institutional. IBKR Pro retail allocation gets prorated to 0.1-share fractions on hot deals. How to buy SpaceX stock →
① Buyable today — any US-equity broker, no underwriter relationship. ② Dollar-cost averaging — IPO allocation is all-or-nothing; ETFs let you split entry across weeks.
③ No lockup — direct IPO buyers face 6-month restrictions; the fund holds the shares, not you. ④ Diversification — XOVR-class broad ETFs come with OpenAI · Stripe · Anthropic exposure as a free side-effect.
As of 2026.05. Five axes: expense ratio · AUM · SpaceX weight · daily liquidity · NAV premium.
| Metric | XOVR | DXYZ | RONB |
|---|---|---|---|
| Issuer | ER Shares | Destiny | Roundhill |
| Structure | open-end ETF | closed-end | open-end ETF |
| Expense ratio | 0.75% | 2.5% | 0.95% |
| AUM | $250M | $80M | $50M |
| SpaceX weight | ~16% | ~23% | 14~22% |
| Daily volume | $5M | $30M | $2M |
| NAV premium | ±2% | +30~120% | +10~25% |
| Liquidity | A+ | A (premium-driven) | B |
ER Shares Crossover Investor ETF. Holds a mix of pre-IPO unicorns and recently-public IPOs. Beyond SpaceX: OpenAI, Anthropic, Stripe, Databricks, Epic Games, plus auto-additions when new unicorns IPO (Reddit was added in 2024).
Structural advantage: open-end means new shares can be created continuously, so price tracks NAV — premium stays within ±2%. The 0.75% expense ratio is below the 1.0–1.5% norm for active strategies.
Destiny Tech100. Closed-end fund (CEF) holding 50+ pre-IPO names with the highest SpaceX weight in the category.
Structural trap: as a CEF, share count is fixed. When demand spikes, price rises above NAV with nothing to anchor it. April 2024 hit +120% premium, then collapsed -60% over the following four months. Currently trading at +30~50% premium (May 2026).
The 2.5% expense ratio is hedge-fund territory and stacks on top of fees inside any underlying private equity holdings.
Roundhill Pre-IPO ETF. Launched 2025, the youngest of the three. Tracks a pre-IPO index where SpaceX weight rebalances quarterly between 14% and 22%.
Pro: open-end, so the premium trap is muted. Con: $50M AUM is thin — daily volume averages $2M, which means 1–2% slippage on moderate orders.
The metric that actually matters: weight after netting out the premium you're paying to enter.
| ETF | Headline % | Premium | Effective % | $1 of SpaceX |
|---|---|---|---|---|
| XOVR | 16.2% | +2% | 15.9% | $0.159 |
| DXYZ | 23% | +50% | 15.3% | $0.153 |
| RONB | 18% | +15% | 15.7% | $0.157 |
Effective % = headline % ÷ (1 + premium).
Example: DXYZ's 23% headline weight at +50% premium means \$1 of NAV trades for \$1.50 — so the same \$1.50 spent on a NAV-tracking ETF gets you 23% / 1.5 = 15.3% of equivalent SpaceX exposure.
Punchline: the headline-weight winner becomes the effective-weight loser once the premium is in. Closed-end premium is a tax on entry that the brochure won't show you.
A closed-end fund hazard that reliably catches retail at the wrong end of the cycle.
① Closed-end structure: no new shares can be created. When demand outstrips supply, price detaches from NAV — open-end peers (XOVR, RONB) issue shares to absorb demand and stay anchored.
② SpaceX scarcity: very few retail-accessible vehicles offer SpaceX exposure at all, and DXYZ has the heaviest weight among them. The premium is the market's price for that uniqueness.
③ FOMO loop: SpaceX news → DXYZ price jumps → ETF "looks more expensive than NAV" → retail thinks something is happening → more buying → premium expands → +120% peaks.
2024.01 → +5%
2024.04 → +120% (peak, SpaceX Series K mark-up)
2024.06 → +60%
2024.09 → -10% (disappointment selloff)
2025.01 → +20%
2025.06 → +35%
2025.12 → +45% (IPO countdown begins)
2026.05 → +50% (current)
→ projected 2026.06 D-7 → +80~100%
→ projected 2026.07 D+1 → -30% (premium collapse)
Option A: skip DXYZ entirely. Use XOVR or RONB.
Option B: hold DXYZ but exit one week before the IPO. Sell at the premium peak.
Option C: only enter when premium is below +20%. The September 2024 dip was such a window.
Expected price behaviour for each ETF at four event windows.
| Phase | XOVR | DXYZ | RONB |
|---|---|---|---|
| D-7 (1 wk pre-IPO) | +5~10% FOMO entry | +30~50% premium peak | +10~15% choppy |
| D-day (IPO open) | +0~5% low vol | -15~30% premium collapse begins | +5~10% choppy |
| D+30 (1 mo) | SpaceX weight auto-rebalances upward (price-cap weighted) | NAV-tracking restored, premium normalises to +5~15% | open-end rebalance, +5% |
| D+180 (lockup expiry) | insider supply pressure, -5~10% transient | NAV -10~20% absorbing insider sales | -5~10% |
Now → D-30: scale into XOVR/RONB on dips. DXYZ only if premium is below +30%.
D-7: stop adding. DXYZ holders consider exiting at premium peak.
D-day → D+7: extreme volatility window. New entries paused; existing positions hold.
D+30 → D+90: ETFs raise their direct SpaceX weights (price-cap weighting catches up). XOVR's SpaceX share rises from 16% toward 22%. The actual buy window — fundamentals + post-event clarity converge.
D+180: lockup expiry creates supply pressure. Direct SpaceX shares re-rate; ETF positions stabilize.
Compounded over 5 years, the expense ratio difference becomes a meaningful return drag.
$10K invested, 5 years, 12% gross CAGR assumption:
XOVR (0.75%) → $17,623 (fees: $652)
RONB (0.95%) → $17,478 (fees: $797)
DXYZ (2.5%) → $16,038 (fees: $2,234)
DXYZ's 2.5% eats 10% of the gross return over five years — and that's before considering premium risk. DXYZ is structurally a wrong fit for long-hold strategies.
All three are US-domiciled — long-term capital gains (15-20% federal) apply if held more than 12 months. Short-term gains (≤12 months) are taxed at ordinary rates. No PFIC issues.
For the ETFs themselves, very little distributable income (the underlying private holdings don't generate dividends), so most of the tax bill comes when you sell. Dividend tax is essentially zero.
Korean residents pay 22% capital gains tax (incl. local) above the ₩2.5M annual exemption. Reportable in May income tax filing. Loss-harvest within the same calendar year for offset.
Three branching questions: holding period, event-driven vs hold, and beta tolerance.
Conservative · Balanced · Aggressive — sleeves of 5–10% of total portfolio value.
SpaceX sleeve: 5% of total portfolio
Allocation:
XOVR: 100% of sleeve
DXYZ: 0%
RONB: 0%
Holding period: 5+ years
Expected CAGR: 10~15%
Max 1Y drawdown: -25%
0.75% expense, broad diversification, NAV-stable. Recommended for 99% of retail readers.
SpaceX sleeve: 7% of total portfolio
Allocation:
XOVR: 70%
RONB: 20%
DXYZ: 10% (premium ≤ +30% only)
Holding period: 3~5 years
Expected CAGR: 14~18%
Max 1Y drawdown: -35%
RONB adds adjacent pre-IPO exposure (Anduril, etc.); a small DXYZ slice opportunistically lifts SpaceX weight. Premium-entry discipline required.
SpaceX sleeve: 10% of total portfolio
Allocation:
XOVR: 50%
EchoStar (SATS) direct: 30%
DXYZ: 15%
RONB: 5%
Holding period: 1~5 years (event-driven)
Expected CAGR: 18~25%
Max 1Y drawdown: -50%
EchoStar (SATS) lifts effective SpaceX beta; DXYZ requires precise premium entry/exit. Active management mindset required.
Deep-dive analysis + live countdown + valuation calculator to back-test your conviction.
📊 The $1.75T Musk Empire IPO →